BioCardia has shared early results from a trial testing its CardiAMP Cell Therapy for people with chronic heart issues. The findings were presented at a major medical conference in Paris. Participants in the trial showed significant improvements in their ability to exercise and reported fewer episodes of chest pain, known as angina. Specifically, they increased their exercise tolerance by an average of nearly three minutes and experienced an 82% reduction in angina episodes within six months of treatment.

These results are particularly relevant for anyone concerned about heart health and looking to maintain an active lifestyle as they age. Improved exercise tolerance can lead to better overall fitness and quality of life, while fewer angina episodes may mean less discomfort and anxiety related to heart conditions. The trial included patients who had already undergone standard treatments, indicating that CardiAMP may offer additional benefits for those who have limited options.

However, it’s important to note that these findings are preliminary. The study is still in the early stages, and the therapy is considered investigational in the United States. This means more research is needed to confirm these benefits and understand the long-term effects. While the results are promising, they should be interpreted with caution until more conclusive evidence is available.

If you’re interested in heart health, maintaining a balanced lifestyle with regular exercise and a heart-healthy diet can be beneficial. Always consult with a healthcare professional before considering new treatments or therapies.

Source: longevity.technology